Jens Kemp - 01 Jan 2024 Form 3 Insider Report for Axogen, Inc. (AXGN)

Role
Chief Marketing Officer
Signature
/s/ Jens Kemp
Issuer symbol
AXGN
Transactions as of
01 Jan 2024
Net transactions value
$0
Form type
3
Filing time
11 Jan 2024, 17:07:27 UTC
Next filing
23 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AXGN Common Stock 30,000 01 Jan 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AXGN Employee Stock Option (right to purchase) 01 Jan 2024 Common Stock 60,000 $8.16 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
F2 All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on March 1, 2027 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 1, 2025 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter.